These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8502233)
1. Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Lemoine A; Gautier JC; Azoulay D; Kiffel L; Belloc C; Guengerich FP; Maurel P; Beaune P; Leroux JP Mol Pharmacol; 1993 May; 43(5):827-32. PubMed ID: 8502233 [TBL] [Abstract][Full Text] [Related]
2. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854 [TBL] [Abstract][Full Text] [Related]
3. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism. Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV Drug Metab Dispos; 1999 Jan; 27(1):102-9. PubMed ID: 9884317 [TBL] [Abstract][Full Text] [Related]
4. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340 [TBL] [Abstract][Full Text] [Related]
5. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Yamazaki H; Shaw PM; Guengerich FP; Shimada T Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734 [TBL] [Abstract][Full Text] [Related]
6. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124 [TBL] [Abstract][Full Text] [Related]
8. Activation of amino-alpha-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Shimada T; Guengerich FP Cancer Res; 1991 Oct; 51(19):5284-91. PubMed ID: 1913651 [TBL] [Abstract][Full Text] [Related]
9. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1996 Jul; 278(1):21-30. PubMed ID: 8764331 [TBL] [Abstract][Full Text] [Related]
10. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Chang TK; Weber GF; Crespi CL; Waxman DJ Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617 [TBL] [Abstract][Full Text] [Related]
11. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450. Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357 [TBL] [Abstract][Full Text] [Related]
12. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches. Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589 [TBL] [Abstract][Full Text] [Related]
13. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479 [TBL] [Abstract][Full Text] [Related]
14. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Labroo RB; Paine MF; Thummel KE; Kharasch ED Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623 [TBL] [Abstract][Full Text] [Related]
15. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Moody DE; Alburges ME; Parker RJ; Collins JM; Strong JM Drug Metab Dispos; 1997 Dec; 25(12):1347-53. PubMed ID: 9394023 [TBL] [Abstract][Full Text] [Related]
16. In vitro identification of the human cytochrome P-450 enzymes involved in the N-demethylation of azelastine. Imai T; Taketani M; Suzu T; Kusube K; Otagiri M Drug Metab Dispos; 1999 Aug; 27(8):942-6. PubMed ID: 10421623 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4. Störmer E; von Moltke LL; Shader RI; Greenblatt DJ Drug Metab Dispos; 2000 Oct; 28(10):1168-75. PubMed ID: 10997935 [TBL] [Abstract][Full Text] [Related]
18. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation. Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998 [TBL] [Abstract][Full Text] [Related]
19. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes. Danie WA; Syrek M; Ryłko Z; Wójcikowski J Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081 [TBL] [Abstract][Full Text] [Related]
20. Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. Venkatakrishnan K; von Moltke LL; Greenblatt DJ J Pharmacol Exp Ther; 2001 Apr; 297(1):326-37. PubMed ID: 11259560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]